Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06248788 · ClinicalTrials.gov registry record
Salivary Immunoglobulin A (sIgA) Normal Range Study
A clinical trial, sponsored by 4Life Research.
- Completed
- Registry status
- 47
- Enrollment target
NCT06248788 is a clinical trial that has completed, run by 4Life Research. The registered enrollment target is 47 participants.
The verdict
NCT06248788 has completed, sponsored by 4Life Research.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
Salivary Immunoglobulin A (sIgA) is a marker of immune system activity. Typically, sIgA is determined by an ELISA test in which samples have to be sent to a specialized laboratory for testing. Investigators have developed a new instrument that is small, portable, and easy to use. This instrument is available for consumers to purchase and test their own sIgA at home.
Interventions
- DEVICE PoC Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-06-19 |
| Est. Completion | 2018-01-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06248788
The ClinicalTrials.gov registry entry for NCT06248788 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 4Life Research, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PoC Device is the first listed.
NCT06248788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06248788 about?
NCT06248788 is a clinical study titled "Salivary Immunoglobulin A (sIgA) Normal Range Study". Salivary Immunoglobulin A (sIgA) is a marker of immune system activity. Typically, sIgA is determined by an ELISA test in which samples have to be sent to a specialized laboratory for testing. Investigators have developed a new instrument that is small, portable, and easy to use. This instrument is ...
What is the current status of trial NCT06248788?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2017-06-19. Estimated completion is 2018-01-20.
What interventions are being tested in trial NCT06248788?
The interventions under investigation include: PoC Device (DEVICE).
Who is sponsoring clinical trial NCT06248788?
This trial is sponsored by 4Life Research, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.